In summary, this study demonstrates that heterologous expression of EGFP–MTA1 facilitates the acquisition of an invasive, metastatic phenotype of PANC-1 pancreatic carcinoma cells. The gene discussed is MTA1; the disease is exocrine pancreatic carcinoma.